KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Receivables - Net: 2013-2025

Historic Receivables - Net for CareDx (CDNA) over the last 12 years, with Sep 2025 value amounting to $47.8 million.

  • CareDx's Receivables - Net fell 28.19% to $47.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.8 million, marking a year-over-year decrease of 28.19%. This contributed to the annual value of $64.6 million for FY2024, which is 26.53% up from last year.
  • CareDx's Receivables - Net amounted to $47.8 million in Q3 2025, which was down 28.97% from $67.4 million recorded in Q2 2025.
  • In the past 5 years, CareDx's Receivables - Net ranged from a high of $30.0 billion in Q1 2021 and a low of $47.8 million during Q3 2025.
  • For the 3-year period, CareDx's Receivables - Net averaged around $59.8 million, with its median value being $60.1 million (2024).
  • As far as peak fluctuations go, CareDx's Receivables - Net spiked by 131,242.76% in 2021, and later crashed by 99.78% in 2022.
  • CareDx's Receivables - Net (Quarterly) stood at $59.8 million in 2021, then grew by 10.96% to $66.3 million in 2022, then fell by 23.00% to $51.1 million in 2023, then rose by 26.53% to $64.6 million in 2024, then dropped by 28.19% to $47.8 million in 2025.
  • Its Receivables - Net stands at $47.8 million for Q3 2025, versus $67.4 million for Q2 2025 and $71.5 million for Q1 2025.